A comprehensive view of Hengan International Group Co. Ltd.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Macquarie maintains Hengan at outperform, noting double-digit growth in tissue sales and flattish volume growth for sanitary napkins in H1, management's plans to focus on new channel investment, product upgrades and promotions to seize more market share
Published:
August 20, 2024
by AASTOCKS (HK)
|
Hengan launches structured tissue products after Toscotec's TADVISION machine start-up at its Xiaogan mill, the first of two ordered; TADVISION is the nation's first TAD machine, boasting quality structured tissue with excellent bulk, softness, absorbency
Published:
April 04, 2024
by Toscotec SPA
|
Daiwa maintains Hengan's outperform rating, as H2 2023 profit outperforms expectation due to lower raw materials costs, operating expense savings; analyst raises 2024-2025 earnings forecast by 5%-7% on higher operating margin forecasts
Published:
March 25, 2024
by AASTOCKS
|
JPMorgan rates Hengan at overweight and lowers target by HK$6 to HK$38, noting 2023 sales miss estimates, but earnings surpass forecasts; management expects gross profit margin to improve further as cost reductions are favorable for full-year performance
Published:
March 22, 2024
by AASTOCKS (HK)
|
Guangdong Hengan Paper starts up two new Andritz PrimeLine tissue machines at its mill in Yunfu, Guangdong, China; the PrimeLineCOMPACT M 1600 machines produce top-quality tissue for facial, toilet, handkerchief and napkin grades from virgin market pulp
Published:
January 26, 2024
by Andritz AG
|
Ask us about our Tissue & Hygiene market view